In a statement, the palace said the veteran royal was taking the treatment positively and wanted to share the news to kill speculation and boost those fighting the menace of cancer.
By: Shubham Ghosh
KING Charles III, who succeeded his mother Queen Elizabeth II to the throne following her death in September 2022, has been diagnosed with a form of cancer, Buckingham Palace revealed on Monday (5).
In a statement, it said, “His Majesty has today commenced a schedule of regular treatments, during which time he has been advised by doctors to postpone public-facing duties.”
It also said that the 75-year-old king was taking the treatment positively and wanted the news of the diagnosis to be shared so that there is no speculation and to “assist public understanding for all those around the world who are affected by cancer”.
Read: Five key events from Charles III’s first year as king
A statement from Buckingham Palace: https://t.co/zmYuaWBKw6
? Samir Hussein pic.twitter.com/xypBLHHQJb
— The Royal Family (@RoyalFamily) February 5, 2024
It was also added that the king is looking forward to returning to full public duty at the earliest.
It is not a prostate cancer but was discovered during the king’s recent treatment for an enlarged prostate, a BBC report said.
Read: Royal recovery: King Charles, Catherine discharged from hospital
The type of cancer has not been revealed.
The king’s public engagements will be deferred and it is likely that other senior royals will help in handling the situation while he undergoes treatment. He will, however, continue with his constitutional role as the head of the state, including paperwork and private meetings.
King Charles III on Monday morning returned to London from Sandringham in Norfolk and the palace said he has begun treatment as an outpatient.
He underwent a prostate procedure at a private London hospital more than a week ago.
For various types of cancer, the probability of getting it grows with age. According to figures, the UK sees on average each year, 36 per cent of new cancer cases in people aged 75 and above.